Abstract
The present review summarizes the existing literature data regarding the development of newer categories of antidiabetic agents, their mechanism of action and their clinical importance. In this paper, a review of the recent patents for the treatment of diabetes will be presented. In recent years significant achievements have been done, including the development of SGLT2 inhibitors, glucokinase activators as well as the role of free fatty acids and bile acid metabolism in the treatment of diabetes are reviewed.
Keywords: Bile acid synthesis, Low density lipoprotein cholesterol, sodium-coupled glucose transporters, free fatty acids, glucokinase activators, SGLT2 inhibitors, Dapagliflozin, Type 2 diabetes mellitus, Diet-induced obesity
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued)
Title: Challenges for the Treatment of Diabetes Mellitus
Volume: 5 Issue: 3
Author(s): Athanasia K. Papazafiropoulou, Marina S. Kardara and Stavros I. Pappas
Affiliation:
Keywords: Bile acid synthesis, Low density lipoprotein cholesterol, sodium-coupled glucose transporters, free fatty acids, glucokinase activators, SGLT2 inhibitors, Dapagliflozin, Type 2 diabetes mellitus, Diet-induced obesity
Abstract: The present review summarizes the existing literature data regarding the development of newer categories of antidiabetic agents, their mechanism of action and their clinical importance. In this paper, a review of the recent patents for the treatment of diabetes will be presented. In recent years significant achievements have been done, including the development of SGLT2 inhibitors, glucokinase activators as well as the role of free fatty acids and bile acid metabolism in the treatment of diabetes are reviewed.
Export Options
About this article
Cite this article as:
K. Papazafiropoulou Athanasia, S. Kardara Marina and I. Pappas Stavros, Challenges for the Treatment of Diabetes Mellitus, Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) 2011; 5 (3) . https://dx.doi.org/10.2174/187221411797265953
DOI https://dx.doi.org/10.2174/187221411797265953 |
Print ISSN 1872-2148 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3334 |
Related Articles
-
Endothelial Microparticles: Mediators or Markers of Endothelial Cell Dysfunction?
Current Hypertension Reviews Possible Targets of Herbals for Type 3 Diabetes: A Review
Current Traditional Medicine Medical Complications in Anorexia and Bulimia Nervosa
Endocrine, Metabolic & Immune Disorders - Drug Targets Metformin: Repurposing Opportunities for Cognitive and Mood Dysfunction
CNS & Neurological Disorders - Drug Targets Association of Oxidative Stress to the Genesis of Anxiety: Implications for Possible Therapeutic Interventions
Current Neuropharmacology Roles of Nicotinic Acetylcholine Receptors in Stem Cell Survival/Apoptosis, Proliferation and Differentiation
Current Molecular Medicine Insights into the Pathogenesis and Intervention of Atherosclerosis
Vascular Disease Prevention (Discontinued) Not a Painless Condition: Rheumatological and Musculoskeletal Symptoms in Type 2 Diabetes, and the Implications for Exercise Participation
Current Diabetes Reviews Influence of Bariatric Surgery on the Expression of Nesfatin-1 in Rats with Type 2 Diabetes Mellitus
Current Pharmaceutical Design PPARs and Diabetes-Associated Atherosclerosis
Current Pharmaceutical Design Model for Gestational Diabetes on Web Based Parameters
Recent Patents on Engineering Naringenin and Atherosclerosis: A Review of Literature
Current Pharmaceutical Biotechnology Long-Term Exposure to Ambient Hydrocarbons Increases Dementia Risk in People Aged 50 Years and above in Taiwan
Current Alzheimer Research Docking and Molecular Dynamics Simulations of Peroxisome Proliferator Activated Receptors Interacting with Pan Agonist Sodelglitazar
Protein & Peptide Letters Molecular Interaction of Human Brain Acetylcholinesterase with a Natural Inhibitor Huperzine-B: An Enzoinformatics Approach
CNS & Neurological Disorders - Drug Targets Glyoxal Induced Transition of Transferrin to Aggregates: Spectroscopic, Microscopic and Molecular Docking Insight
Current Pharmaceutical Biotechnology Pathogenesis and Treatment of Type 2 Diabetic Nephropathy: Lessons from the Spontaneous KK/Ta Mouse Model
Current Diabetes Reviews Angiotensin-TGF-β1 Crosstalk in Human Idiopathic Pulmonary Fibrosis:Autocrine Mechanisms in Myofibroblasts and Macrophages
Current Pharmaceutical Design Domperidone and Long QT Syndrome
Current Drug Safety Targets of Anti-glucocorticoid Therapy for Stress-related Diseases
Recent Patents on CNS Drug Discovery (Discontinued)